-transparent.png){kind=logo}
Rheumatoid arthritis (RA) serum inhibits complement-mediated inhibition of immune precipitation (solubilization). We have isolated inhibitory activity from RA sera and shown that it is a property of IgM-rheumatoid factor (IgM-RF) and, to a lesser extent, IgG-RF.
Related Publications
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
January 1990,
Rheumatology international,
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
November 1980,
Clinical and experimental immunology,
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
September 1984,
Journal of immunology (Baltimore, Md. : 1950),
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
August 1988,
Annals of the rheumatic diseases,
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
March 1982,
Clinical and experimental immunology,
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
May 1986,
Clinical and experimental immunology,
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
March 1982,
Clinical and experimental immunology,
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
January 1990,
Haematologia,
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
February 1986,
Clinical and experimental immunology,
W S Mitchell, and
J K Naama, and
J Veitch, and
K Whaley
November 1987,
Molecular immunology,
